We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.03B
AUM Growth
–
Cap. Flow
+$8.05B
Cap. Flow
% of AUM
100.3%
Top 10 Holdings %
Top 10 Hldgs %
18.06%
Holding
2,281
New
2,279
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$264M |
| 2 |
Johnson & Johnson
JNJ
|
+$229M |
| 3 |
Chevron
CVX
|
+$157M |
| 4 |
Procter & Gamble
PG
|
+$143M |
| 5 |
IBM
IBM
|
+$130M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.36% |
| 2 | Healthcare | 12.61% |
| 3 | Industrials | 12.03% |
| 4 | Financials | 10.68% |
| 5 | Energy | 10.6% |
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Glenmede Trust, which disclosed 2,281 positions worth $8.03B. Its ten largest holdings account for 18% of the portfolio.
Its largest position is ExxonMobil: 2,929,510 shares worth $265M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, followed by Healthcare and Industrials.
- Glenmede Trust's largest Q2 2013 buy was ExxonMobil: 2,929,510 shares worth $265M.
- Glenmede Trust's ten largest holdings make up 18% of its $8.03B portfolio in Q2 2013.
- Glenmede Trust disclosed 2,281 positions in Q2 2013, its first 13F filing on record.
Based on Glenmede Trust's 13F filing for Q2 2013, filed 15 Aug 2013.